ASTER DM HEALTHCARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 360.6 INR | +0.10% |
|
+1.53% | -12.02% |
| May. 29 | Transcript : Aster DM Healthcare Limited, Q4 2024 Earnings Call, May 29, 2024 | |
| May. 28 | Aster Dm Healthcare Limited Proposes Final Dividend for the Financial Year 2023-24 | CI |
| Sales 2024 | 140B 1.67B | Sales 2025 * | 43.07B 516M | Capitalization | 179B 2.15B |
|---|---|---|---|---|---|
| Net income 2024 | 1.29B 15.49M | Net income 2025 * | 3.54B 42.35M | EV / Sales 2024 | 1.94 x |
| Net Debt 2024 | 67.88B 813M | Net cash position 2025 * | 13.62B 163M | EV / Sales 2025 * | 3.84 x |
| P/E ratio 2024 |
157
x | P/E ratio 2025 * |
46.7
x | Employees | 30,330 |
| Yield 2024 |
0.49% | Yield 2025 * |
16.8% | Free-Float | 42.28% |
More Fundamentals
* Assessed data
More news
Latest transcript on Aster DM Healthcare Limited
More press releases
| 1 day | +0.32% | ||
| 1 week | +1.76% | ||
| Current month | -0.71% | ||
| 1 month | +4.94% | ||
| 3 months | -16.16% | ||
| 6 months | -9.96% | ||
| Current year | -11.82% |
1 week
311.10
363.45
1 month
311.10383.00
Current year
311.10558.00
1 year
274.85558.00
3 years
148.00558.00
5 years
78.00558.00
10 years
78.00558.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 86-12-31 | |
| Director of Finance/CFO | - | 23-05-24 | |
| Chief Tech/Sci/R&D Officer | - | 18-09-24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 20-04-10 | |
| Chief Executive Officer | 71 | 86-12-31 | |
| Director/Board Member | 63 | 09-04-19 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 32 M€ | +4.30% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-10 | 360.6 | +0.10% | 641 322 |
| 24-06-07 | 360.2 | +0.81% | 693,382 |
| 24-06-06 | 357.3 | +5.99% | 1,878,491 |
| 24-06-05 | 337.1 | +1.80% | 947,116 |
| 24-06-04 | 331.2 | -6.74% | 1,823,274 |
Delayed Quote NSE India S.E., June 10, 2024 at 02:21 am EDT
More quotes
Aster DM Healthcare Limited is a healthcare service provider. The Company's segments include Hospitals, Clinics, Retail Pharmacies, and Others. The Hospitals segment comprises of hospitals and in-house pharmacies at the hospitals. The Clinics segment comprises of clinics and in-house pharmacies at the clinics. The Retail Pharmacies segment comprises standalone retail pharmacies and optical outlets. The Other segment comprises healthcare consultancy services. The Company operates over 19 hospitals, 13 clinics, 223 pharmacies (operated by Alfaone Retail Pharmacies Private Limited under brand license from Aster), and 224 labs and patient experience centers across five states in India.
Calendar
2024-08-06
- Q1 2025 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
360.2
INR
Average target price
410.8
INR
Spread / Average Target
+14.06%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.82% | 2.15B | |
| -25.47% | 15.13B | |
| -1.80% | 11.77B | |
| +3.48% | 11.71B | |
| +6.18% | 10.36B | |
| +27.17% | 8.54B | |
| -6.29% | 7.42B | |
| +6.08% | 6.72B | |
| +6.08% | 6.32B | |
| -3.96% | 4.3B |
- Stock Market
- Equities
- ASTERDM Stock
